Kristen Gil Buys 3,700 Shares of UnitedHealth Group Incorporated (NYSE:UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The shares were bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the transaction, the director now directly owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

UnitedHealth Group Price Performance

Shares of UNH traded up $18.77 during trading hours on Friday, reaching $293.12. 56,876,207 shares of the company's stock traded hands, compared to its average volume of 5,806,444. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $265.90 billion, a PE ratio of 18.80, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm's 50 day simple moving average is $474.72 and its 200-day simple moving average is $515.82.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.87%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 35.18%.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors have recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at $28,000. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares during the period. Finally, Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter worth $30,000. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on UNH shares. Robert W. Baird decreased their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an "outperform" rating on the stock in a research note on Wednesday. Wells Fargo & Company reduced their price target on UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a research note on Wednesday. Truist Financial dropped their target price on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $560.00 to $350.00 in a report on Wednesday. Finally, Argus cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Monday, April 21st. Six research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $486.00.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.